ED vs KAPA · P/E 18, rev $16.92B vs $18.8M cap
Consolidated Edison Inc (ED) versus Kairos Pharma, Ltd. (KAPA) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Kairos Pharma, Ltd. (KAPA) is a biotechnology company listed on US.
Latest reported ED revenue for 2025-12-31 was $16.92B. Net income was $2.02B. Revenue was up 10.9% from 2024-12-31 to 2025-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
KAPA does not have a complete income-statement cache yet.
ED currently screens at market cap $36.02B and trailing P/E 18.3. KAPA currently screens at market cap $18.8M.
Not investment advice. Open the ED and KAPA stock pages for the full models.
Not investment advice.